Technical Analysis for RNVAD - Rennova Health Inc

Grade Last Price % Change Price Change
grade C 0.003 -18.92% -0.0007
RNVAD closed down 18.92 percent on Monday, December 10, 2018, on 1.82 times normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A N/A Down
See historical RNVAD trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Hot IPO Pullback Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
New 52 Week Low Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
New 52 Week Closing Low Bearish -18.92%
Hot IPO Pullback Bullish Swing Setup -18.92%
Calm After Storm Range Contraction -18.92%

Older signals for RNVAD ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Rennova Health, Inc., together with its subsidiaries, provides a suite of healthcare related products and services to healthcare providers in the United States. The company operates in three segments: Laboratory Services, Supportive Software Solutions, and Decision Support and Informatics Operations. It provides toxicology, clinical pharmacogenetics, and esoteric testing services. The company also offers Advantage, a HIPAA compliant software; Clinlab, a Windows-based Web-enabled laboratory information management system; and Medical Mime, a suite of solutions, which include an optimized Electronic health records (EHR) for substance abuse and behavioral health providers, a dictation-based ambulatory EHR for physician practices, and advanced transcription services. In addition, it develops and markets interpretation and decision support solutions that enhance cancer diagnoses and treatment through actionable data analytics and reporting for oncologists and their patients. Rennova Health, Inc. was founded in 2005 and is headquartered in West Palm Beach, Florida.
Health Cancer Healthcare Providers Microsoft Windows Electronic Health Records Laboratory Services Transcription Services Healthcare Related Products Nextgen Healthcare Information Systems Compliant Software Decision Support Solutions Electronic Health Records In The United States Esoteric Testing Services Interpretation And Decision Support Solutions Pharmacogenetics
Is RNVAD a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 0 bearish and 5 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 0.0299
52 Week Low 0.0028
Average Volume 2,775,638
200-Day Moving Average 0.0
50-Day Moving Average 0.0
20-Day Moving Average 0.0
10-Day Moving Average 0.0072
Average True Range 0.0049
ADX 0.0
+DI 3.3724
-DI 23.4604
Chandelier Exit (Long, 3 ATRs ) 0.0152
Chandelier Exit (Short, 3 ATRs ) 0.0175
Upper Bollinger Band 0.0
Lower Bollinger Band 0.0
Percent B (%b) 0.0
BandWidth 0.0
MACD Line -0.0022
MACD Signal Line -0.0011
MACD Histogram -0.0012
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0051
Resistance 3 (R3) 0.0053 0.0047 0.0048
Resistance 2 (R2) 0.0047 0.0042 0.0047 0.0046
Resistance 1 (R1) 0.0039 0.0039 0.0036 0.0037 0.0045
Pivot Point 0.0033 0.0033 0.0032 0.0033 0.0033
Support 1 (S1) 0.0025 0.0028 0.0022 0.0023 0.0015
Support 2 (S2) 0.0019 0.0025 0.0019 0.0014
Support 3 (S3) 0.0011 0.0019 0.0013
Support 4 (S4) 0.0009